// App-Quantinova.ai

: Mild Chronic Obstructive Pulmonary Disease (COPD) and the Presence of Dyspnea: Inferences from the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Study

Researchers

Presenter

  • M. Cherian

Principal Investigators

  • D. Jensen

  • S. Mursleen

  • E. C. Goodall

  • G. Nadeau

  • W. Tan

  • J. Bourbeau

Medical Centers

  • Department of Medical Oncology, McGill University Health Center, Montreal, QC, Canada

  • Department of Kinesiology & Physical Education, McGill University, Montreal, QC, Canada,

  • GlaxoSmithKline, Mississauga, ON, Canada

  • Value Evidence and Outcomes, GlaxoSmithKline, Brentford, United Kingdom,

  • Centre for Heart Lung Innovation, St. Pauls Hospital/University of British Columbia, Vancouver, BC, Canada

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

  • Tuberculosis

  • Dyspnea

Biomarkers

  • Catalase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved